SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2.52 |
Enterprise Value ($M) | 14.71 |
Book Value ($M) | 1.40 |
Book Value / Share | 0.06 |
Price / Book | 1.80 |
NCAV ($M) | -80.28 |
NCAV / Share | -3.60 |
Price / NCAV | -0.03 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -3.31 |
Return on Assets (ROA) | -1.66 |
Return on Equity (ROE) | -1.90 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.32 |
Current Ratio | 0.34 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.84 |
Assets | 87.52 |
Liabilities | 86.11 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.06 |
Operating Income | -15.88 |
Net Income | -37.41 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -13.58 |
Cash from Investing | -8.65 |
Cash from Financing | 1.04 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | American Financial Group Inc | 7.70 | 53.17 | |
13G/A | Sabby Management, Llc | 4.99 | -23.11 | |
13G | Altos Venture AG | 5.00 | 0.00 | |
13D | Cincinnati Cornerstone Investors BWV I, LLC | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
189,379 | 527,659 | 35.89 | |
52,402 | 14,169 | 369.84 | |
152,405 | 6,587 | 2,313.72 | |
6,410 | 7,445 | 86.10 | |
92,209 | 23,338 | 395.10 | |
(click for more detail) |
Similar Companies | |
---|---|
OCUP – Ocuphire Pharma, Inc. | OCX – OncoCyte Corporation |
OKYO – OKYO Pharma Limited | ONCT – Oncternal Therapeutics, Inc. |
ONCY – Oncolytics Biotech Inc. |
Financial data and stock pages provided by
Fintel.io